EyePoint Pharmaceuticals, Inc. (FRA:PV3B)

EyePoint Pharmaceuticals Revenue

EyePoint Pharmaceuticals had revenue of $966.00K USD in the quarter ending September 30, 2025, a decrease of -90.82%. This brings the company's revenue in the last twelve months to $42.34M, down -7.38% year-over-year. In the year 2024, EyePoint Pharmaceuticals had annual revenue of $43.27M, down -5.97%.

• Revenue (ttm): $42.34M
• Revenue Growth: -7.38%
• P/S Ratio: 28.14
• Revenue / Employee: $256.61K
• Employees: 165
• Market Cap: 1.02B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	43.27M	-2.75M	-5.97%
Dec 31, 2023	46.02M	4.61M	11.14%
Dec 31, 2022	41.40M	4.47M	12.09%
Dec 31, 2021	36.94M	2.50M	7.27%
Dec 31, 2020	34.44M	14.07M	69.10%
Dec 31, 2019	20.37M	15.79M	345.53%
Dec 31, 2018	4.57M	1.61M	54.37%
Sep 30, 2018	2.96M	-	-
Jun 30, 2018	2.96M	-4.58M	-60.72%
Jun 30, 2017	7.54M	5.92M	365.37%
Jun 30, 2016	1.62M	-24.95M	-93.90%
Jun 30, 2015	26.57M	23.09M	664.90%
Jun 30, 2014	3.47M	1.33M	62.06%
Jun 30, 2013	2.14M	-1.38M	-39.22%
Jun 30, 2012	3.53M	-1.44M	-28.98%
Jun 30, 2011	4.97M	-18.09M	-78.46%
Jun 30, 2010	23.05M	10.89M	89.55%
Jun 30, 2009	12.16M	8.69M	249.88%
Jun 30, 2008	3.48M	1.69M	94.73%
Jun 30, 2007	1.79M	749.00K	72.30%
Jun 30, 2006	1.04M	-	-